MyNeo

Curated by Signal

Developer of a bioinformatics platform

Overview

MyNeo provides bioinformatics platform. The platform is focussed on the identification of neoantigens. The platform also helps in the analysis of MHC (sub) type, TMB, CTA gene expression, clinical tumor classification, and others.

Key facts

Founded: 2002
Headquarters: Ghent, Belgium
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Email: Sign up to view
Phone: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Clarity Genomics
Provider of a platform for multi-omics analysis and interpretation of microbiome data
Life Sciences TechnologyBeerse, Belgium
Biogazelle
Transcriptomics-based diagnostics and therapeutics, and qPCR software.
Life Sciences TechnologyGhent, Belgium
Gecet
Lancing device for measuring blood glucose
Life Sciences TechnologyAlken, Belgium

About MyNeo

What does MyNeo do?

MyNeo provides bioinformatics platform.

Where is MyNeo headquartered?

MyNeo is headquartered in Ghent, Belgium.

When was MyNeo founded?

MyNeo was founded in 2002.

Which sector is MyNeo in?

MyNeo operates in Life Sciences Technology.

Who are MyNeo's competitors?

Companies similar to MyNeo include Clarity Genomics, Biogazelle, and Gecet.